FI964083A - Fusogeeniset liposomit ja menetelmät valmistaa ja käyttää niitä - Google Patents

Fusogeeniset liposomit ja menetelmät valmistaa ja käyttää niitä Download PDF

Info

Publication number
FI964083A
FI964083A FI964083A FI964083A FI964083A FI 964083 A FI964083 A FI 964083A FI 964083 A FI964083 A FI 964083A FI 964083 A FI964083 A FI 964083A FI 964083 A FI964083 A FI 964083A
Authority
FI
Finland
Prior art keywords
lipid
outermost
lipid bilayer
liposome
bilayer
Prior art date
Application number
FI964083A
Other languages
English (en)
Swedish (sv)
Other versions
FI964083A0 (fi
Inventor
Austin Bailey
Pieter R Cullis
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of FI964083A publication Critical patent/FI964083A/fi
Publication of FI964083A0 publication Critical patent/FI964083A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI964083A 1994-04-12 1996-10-11 Fusogeeniset liposomit ja menetelmät valmistaa ja käyttää niitä FI964083A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/003996 WO1995027478A1 (en) 1994-04-12 1994-04-12 Fusogenic liposomes and methods of making and using same

Publications (2)

Publication Number Publication Date
FI964083A true FI964083A (fi) 1996-10-11
FI964083A0 FI964083A0 (fi) 1996-10-11

Family

ID=22242444

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964083A FI964083A0 (fi) 1994-04-12 1996-10-11 Fusogeeniset liposomit ja menetelmät valmistaa ja käyttää niitä

Country Status (13)

Country Link
EP (1) EP0758883B1 (fi)
JP (1) JP3804025B2 (fi)
KR (1) KR100315132B1 (fi)
AT (1) ATE234605T1 (fi)
AU (1) AU689479B2 (fi)
CA (1) CA2187748C (fi)
DE (1) DE69432320T2 (fi)
DK (1) DK0758883T3 (fi)
ES (1) ES2196028T3 (fi)
FI (1) FI964083A0 (fi)
NO (1) NO318814B1 (fi)
NZ (1) NZ268146A (fi)
WO (1) WO1995027478A1 (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339069B1 (en) 1996-10-15 2002-01-15 Elan Pharmaceuticalstechnologies, Inc. Peptide-lipid conjugates, liposomes and lipsomal drug delivery
DE69723473T2 (de) * 1996-10-15 2004-05-27 The Liposome Co., Inc. Peptid-lipid konjugate, liposomen und liposomale arzneimittelverabreichung
US6835395B1 (en) 1997-05-14 2004-12-28 The University Of British Columbia Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles
JP4656675B2 (ja) 1997-05-14 2011-03-23 ユニバーシティー オブ ブリティッシュ コロンビア 脂質小胞への荷電した治療剤の高率封入
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
WO2001015726A2 (en) * 1999-08-27 2001-03-08 Inex Pharmaceuticals Corp. Compositions for stimulating cytokine secretion and inducing an immune response
MXPA05010499A (es) * 2003-03-31 2006-05-25 Johnson & Johnson Particulas lipidicas que tienen un revestimiento lipidico asimetrico y metodo de preparacion de las mismas.
JP4787818B2 (ja) 2005-01-28 2011-10-05 独立行政法人科学技術振興機構 脱水縮合反応により相転移を生じ得る分子集合体およびその相転移方法
US20100215582A1 (en) * 2007-05-14 2010-08-26 Konica Minolta Holdings, Inc. Liposome and method for producing liposome
US9937128B2 (en) 2009-08-03 2018-04-10 The University Of North Carolina At Chapel Hill Liposomes comprising a calcium phosphate-containing precipitate
DK3338765T3 (en) 2009-12-01 2019-03-04 Translate Bio Inc STEROID DERIVATIVE FOR THE SUPPLY OF MRNA IN HUMANGENETIC DISEASES
PL2717893T3 (pl) 2011-06-08 2019-12-31 Translate Bio, Inc. Kompozycje nanocząstek lipidowych i sposoby do dostarczania mRNA
WO2013185067A1 (en) 2012-06-08 2013-12-12 Shire Human Genetic Therapies, Inc. Nuclease resistant polynucleotides and uses thereof
BR112015022660A2 (pt) 2013-03-14 2017-10-31 Shire Human Genetic Therapies métodos para a purificação de rna mensageiro
ES2689523T3 (es) 2013-03-14 2018-11-14 Translate Bio, Inc. Composiciones a base de ARNM del gen CFTR y métodos y usos relacionados
EA201992208A1 (ru) 2013-10-22 2020-07-31 Транслейт Био, Инк. ЛЕЧЕНИЕ ФЕНИЛКЕТОНУРИИ С ПРИМЕНЕНИЕМ мРНК
EP3501605B1 (en) 2013-10-22 2023-06-28 Translate Bio, Inc. Mrna therapy for argininosuccinate synthetase deficiency
CN110511927A (zh) 2014-04-25 2019-11-29 川斯勒佰尔公司 信使rna的纯化方法
EA201991747A1 (ru) 2017-02-27 2020-06-04 Транслейт Био, Инк. НОВАЯ КОДОН-ОПТИМИЗИРОВАННАЯ мРНК CFTR
US11173190B2 (en) 2017-05-16 2021-11-16 Translate Bio, Inc. Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR
AU2019325702A1 (en) 2018-08-24 2021-02-25 Translate Bio, Inc. Methods for purification of messenger RNA

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946787A (en) * 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
WO1987007530A1 (en) * 1986-06-16 1987-12-17 The Liposome Company, Inc. Induction of asymmetry in vesicles
JPH0395118A (ja) * 1989-09-07 1991-04-19 Green Cross Corp:The プロスタグランジン含有脂肪小体製剤
DE4013632A1 (de) * 1990-04-27 1991-10-31 Max Planck Gesellschaft Liposomen mit positiver ueberschussladung
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells

Also Published As

Publication number Publication date
CA2187748C (en) 2007-04-10
AU7091594A (en) 1995-10-30
NZ268146A (en) 1997-10-24
NO964284D0 (no) 1996-10-09
NO318814B1 (no) 2005-05-09
DE69432320D1 (de) 2003-04-24
NO964284L (no) 1996-10-09
EP0758883B1 (en) 2003-03-19
JP3804025B2 (ja) 2006-08-02
KR100315132B1 (ko) 2002-06-26
FI964083A0 (fi) 1996-10-11
EP0758883A1 (en) 1997-02-26
CA2187748A1 (en) 1995-10-19
ATE234605T1 (de) 2003-04-15
AU689479B2 (en) 1998-04-02
JPH09511521A (ja) 1997-11-18
WO1995027478A1 (en) 1995-10-19
DK0758883T3 (da) 2003-06-02
ES2196028T3 (es) 2003-12-16
DE69432320T2 (de) 2003-12-04

Similar Documents

Publication Publication Date Title
FI964083A (fi) Fusogeeniset liposomit ja menetelmät valmistaa ja käyttää niitä
Hofland et al. Estradiol permeation from nonionic surfactant vesicles through human stratum corneum in vitro
ES2167308T3 (es) Un sistema de distribucion de fosfolipidos.
ATE286718T1 (de) Temperatursensitive liposomale formulierung
ES2123284T3 (es) Un sistema de suministro liposomico para agentes biologicamente activos.
AU4711296A (en) Method for loading lipid vesicles
CA2013755A1 (en) Medicinal emulsions
DE69425901T2 (de) Vesikel mit gesteuerter wirkstofffreisetzung
EP0171710A3 (en) Process for preparing liposome composition
DK0831779T3 (da) Fremgangsmåde til fremstilling af liposompræparat
ES2053678T3 (es) Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular.
PT883602E (pt) Compostos lipidicos e sua utilizacao por exemplo em lipossomas
HU9203141D0 (en) Synthetican membrane bubbles containing functionally active fusional peptones being medicament transferring systems
NZ503293A (en) Liposomal camptothecin formulations also comprising at least one phospholipid
MXPA97007996A (es) Preparado para el transporte de sustancias activas a traves de barreras.
DK0592446T3 (da) Fyldningsteknik til fremstilling af lægemiddelholdige liposomer
CA2168260A1 (en) Biphasic Multilamellar Lipid Vesicles
ES8608862A1 (es) Un procedimiento para estabilizar particulas micelares y aumentar su duracion en estado preparado.
ATE260643T1 (de) System zur verabreichung makromolekularer wirkstoffe auf der basis von membran-mimetischen amphiphilen in aerosolform
ES2078510T3 (es) Dispersion acuosa de vesiculas de fosfolipidos, procedimiento para su fabricacion y su uso.
DE69528170D1 (de) Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen
IT8125135A0 (it) Procedimento per l'idrolizzazione in sito di una membrana permeabile agli ioni di una cella elettrolitica utilizzante tale membrana.
FI103178B (fi) Menetelmä vaikuttavaa ainetta sisältävien vesipohjaisten liposomisuspe nsioiden valmistamiseksi
GEP19991819B (en) Method for Production of Therapeutic Form of Carbamazepin with Retarded Active Substance Release
Welsh et al. Use of liposomes to introduce substances into pancreatic islet cells

Legal Events

Date Code Title Description
MA Patent expired